Fling M E, Kope J, Richards C
Wellcome Research Laboratories, Research Triangle Park, North Carolina 27709.
Plasmid. 1988 Jan;19(1):30-8. doi: 10.1016/0147-619x(88)90060-1.
The plasmid pAZ1, which determines trimethoprim and sulfonamide resistance, was characterized by restriction endonuclease mapping. The restriction map was identical to that of the incQ plasmid RSF1010 over a 5.1-kbp region. The type III dihydrofolate reductase gene was cloned, and the DNA sequence was determined. The predicted protein had 162 amino acid residues, and it was more closely related to the gram-negative bacterial chromosomal dihydrofolate reductases than to other plasmid or vertebrate dihydrofolate reductases. Sequence identity was 51% with the Escherichia coli enzyme and 44% with the Neisseria gonorrhoeae enzyme.
决定甲氧苄啶和磺胺耐药性的质粒pAZ1通过限制性内切酶图谱进行了表征。在一个5.1千碱基对的区域内,其限制性图谱与IncQ质粒RSF1010的图谱相同。克隆了III型二氢叶酸还原酶基因,并测定了其DNA序列。预测的蛋白质有162个氨基酸残基,与革兰氏阴性菌染色体二氢叶酸还原酶的关系比与其他质粒或脊椎动物二氢叶酸还原酶的关系更密切。与大肠杆菌的酶的序列同一性为51%,与淋病奈瑟菌的酶的序列同一性为44%。